{
    "startDate": "2019-01-01",
    "endDate": "2019-06-30",
    "year": "2019",
    "quarter": "Q2",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 272523000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1989508000
            },
            {
                "label": "Contracts receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 31615000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 18505000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 102071000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 2414222000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 135349000
            },
            {
                "label": "Patents, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 26056000
            },
            {
                "label": "Long-term deferred tax assets",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 276360000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 25778000
            },
            {
                "label": "Amortization of patents",
                "concept": "Assets",
                "unit": "usd",
                "value": 2877765000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 15628000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 20049000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 49681000
            },
            {
                "label": "Income taxes payable",
                "concept": "AccruedIncomeTaxesCurrent",
                "unit": "usd",
                "value": 4035000
            },
            {
                "label": "Current portion of long-term obligations",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 14432000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 137388000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 241213000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 516584000
            },
            {
                "label": "1 percent convertible senior notes",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": 586797000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 59878000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1420563000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 140,393,074 and 137,928,828 shares issued and outstanding at June 30, 2019 (unaudited) and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 140000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 2177222000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -24252000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -883726000
            },
            {
                "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 1269384000
            },
            {
                "label": "Income (loss) before income tax (expense) benefit",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 187818000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1457202000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 2877765000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 80873000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 6253000
            },
            {
                "label": "Amortization of patents",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 948000
            },
            {
                "label": "Amortization of premium (discount) on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 5163000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 957000
            },
            {
                "label": "Amortization of convertible senior notes discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 17661000
            },
            {
                "label": "Payments of tax withholdings related to vesting of share-based awards",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 87437000
            },
            {
                "label": "Non-cash losses related to patents, licensing and property, plant and equipment",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 203000
            },
            {
                "label": "Provision for deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 14436000
            },
            {
                "label": "Contracts receivable",
                "concept": "IncreaseDecreaseInContractWithCustomerAsset",
                "unit": "usd",
                "value": 16255000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 5736000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 6372000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -16104000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -9219000
            },
            {
                "label": "Deferred contract revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -73643000
            },
            {
                "label": "Net cash provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 80594000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 1049274000
            },
            {
                "label": "Proceeds from short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 877966000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 7243000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -180861000
            },
            {
                "label": "Proceeds from equity awards",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 102004000
            },
            {
                "label": "Payments of tax withholdings related to vesting of employee stock awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 8034000
            },
            {
                "label": "Proceeds from the issuance of common stock to Biogen",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 93970000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -6297000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 4776000
            },
            {
                "label": "Right-of-use assets obtained in exchange for lease obligations",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": 13920000
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 461026000
            },
            {
                "label": "Cost of Products Sold [Abstract]",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 2406000
            },
            {
                "label": "Selling, General and Administrative [Member]",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 143332000
            },
            {
                "label": "Total operating expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 358320000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 102706000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 25880000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 23402000
            },
            {
                "label": "Other income (expenses)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -192000
            },
            {
                "label": "Income (loss) before income tax (expense) benefit",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 104992000
            },
            {
                "label": "Provision for deferred income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 24119000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 80873000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -2694000
            },
            {
                "label": "Adjustments to reconcile net loss to net cash provided by operating activities:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 83567000
            },
            {
                "label": "Basic net income (loss) per share (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.62
            },
            {
                "label": "Shares used in computing basic net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 139419000
            },
            {
                "label": "Diluted net income per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.61
            },
            {
                "label": "Shares used in computing diluted net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 142499000
            },
            {
                "label": "Unrealized gains (losses) on debt securities, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 7775000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -11000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 88637000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -2696000
            },
            {
                "label": "Comprehensive income (loss) attributable to Ionis Pharmaceuticals, Inc. stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 91333000
            }
        ]
    }
}